Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at Third Annual Marcum MicroCap Conference

EWING, N.J., May 22, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
May 12, 2014 16:01 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Business Update and First Quarter 2014 Financial Results

EWING, N.J., May 12, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today reported business...
May 12, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Secures Loan Agreement With Hercules Technology Growth Capital

EWING, N.J., May 12, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
May 05, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014

EWING, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it...
March 26, 2014 16:01 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Start of Clinical Study of CPX-351 in Relapsed/Refractory Higher Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients

EWING, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced...
March 24, 2014 16:01 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces Business Update and Fourth Quarter and Full Year 2013 Financial Results

EWING, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today reported...
March 18, 2014 16:01 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Report Fourth Quarter and Year-End 2013 Financial Results on March 24, 2014

EWING, N.J., March 18, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc., (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
February 03, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Announces New Date and Time for Presentation at 16th Annual BIO CEO and Investor Conference

EWING, N.J., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
January 14, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals to Present at Upcoming Healthcare Conferences

EWING, N.J., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
January 09, 2014 08:30 ET | Source: Celator Pharmaceuticals, Inc.

Celator(R) Pharmaceuticals Reaches 50% Enrollment for CPX-351 Phase 3 Study

EWING, N.J., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...